Trademark: 78670229
Word
CAPIDIOV
Status
Dead
Status Code
710
Status Date
Friday, October 11, 2013
Serial Number
78670229
Registration Number
3214868
Registration Date
Tuesday, March 6, 2007
Mark Type
4000
Filing Date
Thursday, July 14, 2005
Published for Opposition
Tuesday, December 19, 2006
Cancellation Date
Friday, October 11, 2013

Trademark Owner History
Novartis AG - Original Registrant

Classifications
5 Pharmaceutical preparations for the prevention and treatment of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, pharmaceutical preparations treating bacteria-based diseases, antivirals, anti-biotics, anti-fungals

Trademark Events
Oct 11, 2013
Cancelled Sec. 8 (6-Yr)
Jun 21, 2009
Teas Change Of Correspondence Received
Mar 6, 2007
Registered-Principal Register
Dec 19, 2006
Published For Opposition
Nov 29, 2006
Notice Of Publication
Oct 31, 2006
Law Office Publication Review Completed
Oct 27, 2006
Assigned To Lie
Oct 26, 2006
Approved For Pub - Principal Register
Oct 24, 2006
Teas/Email Correspondence Entered
Oct 13, 2006
Correspondence Received In Law Office
Oct 13, 2006
Teas Response To Office Action Received
May 4, 2006
Non-Final Action E-Mailed
May 4, 2006
Non-Final Action Written
Apr 21, 2006
Teas/Email Correspondence Entered
Apr 12, 2006
Correspondence Received In Law Office
Apr 12, 2006
Teas Response To Office Action Received
Jan 23, 2006
Letter Of Suspension E-Mailed
Jan 23, 2006
Suspension Letter Written
Jan 12, 2006
Assigned To Examiner
Jan 10, 2006
Assigned To Examiner
Nov 16, 2005
Teas Change Of Correspondence Received
Nov 7, 2005
Teas Change Of Correspondence Received
Jul 19, 2005
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24